Hi, Thanks for writing in. There is sufficient medical literature on streptococcus bovis explaining the common features on human infection with this bacteria. This organism is found in the intestinal flora of 10% of the healthy population and in 29%–55% of patients with inflammatory bowel diseases or colon cancer. Studies show that S. bovis is increasingly recognized as a cause of infective endocarditis in southern Europe but not in the United States. It is also associated with chronic liver disease. Route of infection is by spontaneous bacteremia, via tumoral neoangiogenesis and vessel wall necrosis, may lead to valve colonization and endocarditis. All strains are susceptible to penicillin, ampicillin, vancomycin, and teicoplanin. Prevention of complications is by early detection and treatment.